What checks are necessary for lurbinectedin's long term use?

What blood tests are needed during extended lurbinectedine treatment?

Lurbinectedin dosing is paused or reduced when absolute neutrophil count falls below 500 cells/mm³ or platelet count falls below 50,000/mm³. Weekly CBC monitoring is required for the first two cycles, then every cycle thereafter, with extra checks if fever or infection develops.

How often do liver enzymes need watching?

ALT, AST, bilirubin, and alkaline phosphatase are measured before each dose. Treatment is held if ALT or AST exceeds 3× ULN with bilirubin above 2× ULN, or if isolated ALT/AST rises above 5× ULN. Once values normalize, dosing may resume at a reduced level.

What cardiac monitoring is advised?

Baseline ECG is obtained before starting therapy. Additional ECGs are performed if symptoms such as palpitations or dizziness appear, because QT prolongation has been reported.

Are kidney-function tests required?

Serum creatinine is checked at baseline and before each cycle. Dose adjustments follow standard guidelines when creatinine clearance drops below 60 mL/min.

What infection-prevention steps should patients follow?

Patients receive education on fever thresholds (≥38.3 °C once or ≥38.0 °C sustained) and are advised to seek care immediately. Prophylactic G-CSF is considered for patients with prior grade 3–4 neutropenia.

Can the drug be continued past disease progression?

Continuation beyond progression is not supported by trial data. Treatment is typically stopped at radiographic or clinical progression, unacceptable toxicity, or patient choice.

When do patents limit generic availability?

Lurbinectedin’s composition-of-matter patent expires in 2034 in the United States, according to DrugPatentWatch.com. Secondary patents on formulation and use may extend protection further.